{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:00:54Z","timestamp":1782216054415,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,2]]},"DOI":"10.7759\/cureus.31006","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T14:02:58Z","timestamp":1667397778000},"source":"Crossref","is-referenced-by-count":7,"title":["Overlapping Myocarditis and Postural Orthostatic Tachycardia Syndrome After COVID-19 Messenger RNA Vaccination: A Case Report"],"prefix":"10.7759","author":[{"given":"Yuichi","family":"Sanada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehisa","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Centers for Disease Control and Prevention. Pfizer-BioNTech COVID-19 vaccine reactions and adverse events. (2022). Accessed. October 10, 2022: https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/pfizer\/reactogenicity.html."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention. Selected adverse events reported after COVID-19 vaccination. (2022). Accessed. October 10, 2022: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/safety\/adverse-events.html.","DOI":"10.3390\/vaccines10030482"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12852","article-title":"Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management","volume":"285","author":"Fedorowski A","year":"2019","unstructured":"Fedorowski A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management. J Intern Med. 2019, 285:352-66. 10.1111\/joim.12852","journal-title":"J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.11.059","article-title":"Postural orthostatic tachycardia\u00a0syndrome: JACC Focus Seminar","volume":"73","author":"Bryarly M","year":"2019","unstructured":"Bryarly M, Phillips LT, Fu Q, Vernino S, Levine BD. Postural orthostatic tachycardia\u00a0syndrome: JACC Focus Seminar. J Am Coll Cardiol. 2019, 73:1207-28. 10.1016\/j.jacc.2018.11.059","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-1673","article-title":"Pediatric disorders of orthostatic intolerance","volume":"141","author":"Stewart JM","year":"2018","unstructured":"Stewart JM, Boris JR, Chelimsky G, et al.. Pediatric disorders of orthostatic intolerance. Pediatrics. 2018, 141:e20171673. 10.1542\/peds.2017-1673","journal-title":"Pediatrics"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2021.102828","article-title":"Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - part 1","volume":"235","author":"Vernino S","year":"2021","unstructured":"Vernino S, Bourne KM, Stiles LE, et al.. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - part 1. Auton Neurosci. 2021, 235:102828. 10.1016\/j.autneu.2021.102828","journal-title":"Auton Neurosci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7027e2","article-title":"Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices - United States, June 2021","volume":"70","author":"Gargano JW","year":"2021","unstructured":"Gargano JW, Wallace M, Hadler SC, et al.. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices - United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021, 70:977-82. 10.15585\/mmwr.mm7027e2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056583","article-title":"Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults: suspected myocarditis after COVID-19 vaccination","volume":"145","author":"Truong DT","year":"2022","unstructured":"Truong DT, Dionne A, Muniz JC, et al.. Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults: suspected myocarditis after COVID-19 vaccination. Circulation. 2022, 145:345-56. 10.1161\/CIRCULATIONAHA.121.056583","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2018.05.004","article-title":"Postural orthostatic tachycardia syndrome in children and adolescents","volume":"215","author":"Boris JR","year":"2018","unstructured":"Boris JR. Postural orthostatic tachycardia syndrome in children and adolescents. Auton Neurosci. 2018, 215:97-101. 10.1016\/j.autneu.2018.05.004","journal-title":"Auton Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-015-0583-8","article-title":"Postural tachycardia syndrome: beyond orthostatic intolerance","volume":"15","author":"Garland EM","year":"2015","unstructured":"Garland EM, Celedonio JE, Raj SR. Postural tachycardia syndrome: beyond orthostatic intolerance. Curr Neurol Neurosci Rep. 2015, 15:60. 10.1007\/s11910-015-0583-8","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00261","article-title":"Long-term outcomes of children and adolescents with postural tachycardia syndrome after conventional treatment","volume":"7","author":"Tao C","year":"2019","unstructured":"Tao C, Lu W, Lin J, et al.. Long-term outcomes of children and adolescents with postural tachycardia syndrome after conventional treatment. Front Pediatr. 2019, 7:261. 10.3389\/fped.2019.00261","journal-title":"Front Pediatr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10070991","article-title":"COVID-19 vaccination might induce postural orthostatic tachycardia syndrome: a case report","volume":"10","author":"Hermel M","year":"2022","unstructured":"Hermel M, Sweeney M, Abud E, et al.. COVID-19 vaccination might induce postural orthostatic tachycardia syndrome: a case report. Vaccines (Basel). 2022, 10:991. 10.3390\/vaccines10070991","journal-title":"Vaccines (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14837","article-title":"A case of postural orthostatic tachycardia syndrome secondary to the messenger RNA COVID-19 vaccine","volume":"13","author":"Reddy S","year":"2021","unstructured":"Reddy S, Reddy S, Arora M. A case of postural orthostatic tachycardia syndrome secondary to the messenger RNA COVID-19 vaccine. Cureus. 2021, 13:e14837. 10.7759\/cureus.14837","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-022-00880-3","article-title":"Postural orthostatic tachycardia syndrome after mRNA COVID-19 vaccine","volume":"32","author":"Eldokla AM","year":"2022","unstructured":"Eldokla AM, Numan MT. Postural orthostatic tachycardia syndrome after mRNA COVID-19 vaccine. Clin Auton Res. 2022, 32:307-11. 10.1007\/s10286-022-00880-3","journal-title":"Clin Auton Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-022-02002-2","article-title":"A case of transient POTS following COVID-19 vaccine","volume":"122","author":"Park J","year":"2022","unstructured":"Park J, Kim S, Lee J, An JY. A case of transient POTS following COVID-19 vaccine. Acta Neurol Belg. 2022, 122:1081-3. 10.1007\/s13760-022-02002-2","journal-title":"Acta Neurol Belg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/120806-overlapping-myocarditis-and-postural-orthostatic-tachycardia-syndrome-after-covid-19-messenger-rna-vaccination-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:53Z","timestamp":1707508073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/120806-overlapping-myocarditis-and-postural-orthostatic-tachycardia-syndrome-after-covid-19-messenger-rna-vaccination-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.31006","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,2]]}}}